Alpha 2.0
Login Register
» Articles » PMID: 37819955

Shiga Toxin-Producing and the Hemolytic-Uremic Syndrome

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2023 Oct 11
PMID 37819955
Authors
Stephen B Freedman
Nicole C A J van de Kar
Phillip I Tarr
Affiliations
Soon will be listed here.
Citing Articles

SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins.

Wu J, Xu S, Li Z, Cong B, Yang Z, Yang Z Emerg Microbes Infect. 2025; 14(1):2467781.

PMID: 39945674 PMC: 11873982. DOI: 10.1080/22221751.2025.2467781.

Model-informed repurposing of eliglustat for treatment and prophylaxis of Shiga toxin-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) in children.

Wolthuis D, Freriksen J, Ter Avest M, Kartha R, de Wildt S, Wijnsma K Pediatr Nephrol. 2025; .

PMID: 39900743 DOI: 10.1007/s00467-025-06688-3.

Genotypic analysis of Shiga toxin-producing clonal complex 17 in England and Wales, 2014-2022.

Poh C, Rodwell E, Godbole G, Jenkins C J Med Microbiol. 2024; 73(11).

PMID: 39508726 PMC: 11542628. DOI: 10.1099/jmm.0.001928.

Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome.

Wegener J, Dennhardt S, Loeffler I, Coldewey S Front Immunol. 2024; 15:1469353.

PMID: 39450175 PMC: 11499141. DOI: 10.3389/fimmu.2024.1469353.

Vacation in Egypt associated with Shiga toxin-producing infection in children and adolescents, northern Italy, 2023.

Ria T, Mancuso M, Daprai L, Liporace M, Gazzola A, Arnaboldi S Euro Surveill. 2024; 29(30).

PMID: 39056198 PMC: 11274844. DOI: 10.2807/1560-7917.ES.2024.29.30.2400056.